[Form 4] Equitable Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Equitable Holdings, Inc. insider activity: President and CEO Mark Pearson reported several equity transactions dated 01/20/2026. He exercised 27,200 employee stock options at an exercise price of $23.18 per share, receiving the same number of shares of common stock. On the same date, he sold 33,838 shares of common stock at a weighted average price of $46.1059 and an additional 5,862 shares at a weighted average price of $46.7701.
The filing states that these option exercises and sales were carried out under a Rule 10b5-1 trading plan adopted on May 16, 2025. Following the reported transactions, Pearson directly beneficially owned 652,945.01 shares of Equitable Holdings common stock, which includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan, as well as 163,200 employee stock options.
Positive
- None.
Negative
- None.
Insights
Pre-planned CEO option exercise and share sales under a Rule 10b5-1 plan.
Equitable Holdings’ President and CEO Mark Pearson exercised 27,200 employee stock options at an exercise price of $23.18 per share on 01/20/2026, converting them into common stock. He then sold 33,838 shares at a weighted average price of $46.1059 and 5,862 shares at a weighted average price of $46.7701 on the same date. These transactions are typical for executives managing compensation tied to stock options.
The filing specifies that both the option exercise and related sales were executed pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2025. Such plans are designed to structure trades in advance and help address concerns about trading on material nonpublic information. After the transactions, Pearson directly held 652,945.01 common shares, including Restricted Stock Units and 11,011 shares from the Employee Stock Purchase Plan, along with 163,200 stock options.
The pre-planned nature of the trades and the remaining sizable equity stake suggest these are routine compensation and liquidity events rather than a clear signal of changing views about the company. Future company filings may provide additional context on any subsequent equity awards or further use of the 2019 Omnibus Incentive Plan referenced in the option grant footnote.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 27,200 | $23.18 | $630K |
| Exercise | Common Stock | 27,200 | $23.18 | $630K |
| Sale | Common Stock | 33,838 | $46.1059 | $1.56M |
| Sale | Common Stock | 5,862 | $46.7701 | $274K |
Footnotes (1)
- The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025. Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan. This transaction was executed in multiple trades at prices ranging from $45.6350 to $46.6349. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. This transaction was executed in multiple trades at prices ranging from $46.6350 to $46.9600 The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.